Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis
Healthcare visits were reduced during the COVID-19 pandemic, causing disturbances in sustainable MAFLD monitoring. Telemedicine acts to maintain connectivity between patients and healthcare professionals. This review aimed to assess the role of telemedicine in monitoring MAFLD during the pandemic. D...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-03-01
|
| Series: | Journal of Personalized Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-4426/14/3/281 |
| _version_ | 1797240371530432512 |
|---|---|
| author | Femmy Nurul Akbar Safira Rosiana Choirida Ahmad Zaqi Muttaqin Fika Ekayanti Hoirun Nisa Hari Hendarto |
| author_facet | Femmy Nurul Akbar Safira Rosiana Choirida Ahmad Zaqi Muttaqin Fika Ekayanti Hoirun Nisa Hari Hendarto |
| author_sort | Femmy Nurul Akbar |
| collection | DOAJ |
| description | Healthcare visits were reduced during the COVID-19 pandemic, causing disturbances in sustainable MAFLD monitoring. Telemedicine acts to maintain connectivity between patients and healthcare professionals. This review aimed to assess the role of telemedicine in monitoring MAFLD during the pandemic. Databases searched included <i>l</i> PubMed Central and ScienceDirect from 2020 to 2023. Assessment with The Cochrane Risk of Bias for randomized controlled trials (RCTs) and the Newcastle-Ottawa scale for non-RCTs systematic reviews. Meta-analyses employing a random-effect model were performed to determine the pooled mean difference (MD) and <i>p</i>-value. The results showed three RCT and two non-RCT (<i>n</i> = 239) with 56.9% males and a mean age of 51.3 years. The median intervention duration was 5.5 months. The parameters assessed included body weight (BW), body mass index (BMI), waist circumference, liver function (AST/ALT), lipid profile, HbA1c, and others. Meta-analysis revealed that telemedicine had a significant effect on improving outcomes for BW (MD −2.81: 95% CI, −4.11, −1.51, <i>p</i> < 0.0001) and BMI (MD −1.01: 95% CI, −1.47, −0.55, <i>p</i> < 0.0001) compared to standard care, while the AST/ALT levels were not significantly reduced. Some biochemical markers decreased based on the systematic reviews. In conclusion, telemedicine using mobile-based applications could be an option for monitoring lifestyle modification in MAFLD patients facing the COVID-19 pandemic. |
| first_indexed | 2024-04-24T18:06:22Z |
| format | Article |
| id | doaj.art-cee38321e9c0465dba56951e93c103a8 |
| institution | Directory Open Access Journal |
| issn | 2075-4426 |
| language | English |
| last_indexed | 2024-04-24T18:06:22Z |
| publishDate | 2024-03-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Personalized Medicine |
| spelling | doaj.art-cee38321e9c0465dba56951e93c103a82024-03-27T13:50:09ZengMDPI AGJournal of Personalized Medicine2075-44262024-03-0114328110.3390/jpm14030281Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-AnalysisFemmy Nurul Akbar0Safira Rosiana Choirida1Ahmad Zaqi Muttaqin2Fika Ekayanti3Hoirun Nisa4Hari Hendarto5Department of Internal Medicine, Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, South Tangerang 15419, Banten, IndonesiaDepartment of Internal Medicine, Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, South Tangerang 15419, Banten, IndonesiaDepartment of Internal Medicine, Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, South Tangerang 15419, Banten, IndonesiaDepartment of Community Medicine, Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, South Tangerang 15419, Banten, IndonesiaDepartment of Public Health, Faculty of Health Sciences, Universitas Islam Negeri Syarif Hidayatullah Jakarta, South Tangerang 15419, Banten, IndonesiaDepartment of Internal Medicine, Faculty of Medicine, Universitas Islam Negeri Syarif Hidayatullah Jakarta, South Tangerang 15419, Banten, IndonesiaHealthcare visits were reduced during the COVID-19 pandemic, causing disturbances in sustainable MAFLD monitoring. Telemedicine acts to maintain connectivity between patients and healthcare professionals. This review aimed to assess the role of telemedicine in monitoring MAFLD during the pandemic. Databases searched included <i>l</i> PubMed Central and ScienceDirect from 2020 to 2023. Assessment with The Cochrane Risk of Bias for randomized controlled trials (RCTs) and the Newcastle-Ottawa scale for non-RCTs systematic reviews. Meta-analyses employing a random-effect model were performed to determine the pooled mean difference (MD) and <i>p</i>-value. The results showed three RCT and two non-RCT (<i>n</i> = 239) with 56.9% males and a mean age of 51.3 years. The median intervention duration was 5.5 months. The parameters assessed included body weight (BW), body mass index (BMI), waist circumference, liver function (AST/ALT), lipid profile, HbA1c, and others. Meta-analysis revealed that telemedicine had a significant effect on improving outcomes for BW (MD −2.81: 95% CI, −4.11, −1.51, <i>p</i> < 0.0001) and BMI (MD −1.01: 95% CI, −1.47, −0.55, <i>p</i> < 0.0001) compared to standard care, while the AST/ALT levels were not significantly reduced. Some biochemical markers decreased based on the systematic reviews. In conclusion, telemedicine using mobile-based applications could be an option for monitoring lifestyle modification in MAFLD patients facing the COVID-19 pandemic.https://www.mdpi.com/2075-4426/14/3/281telemedicinemetabolic dysfunction-associated fatty liver diseasemonitorlifestyle modificationCOVID-19 pandemic |
| spellingShingle | Femmy Nurul Akbar Safira Rosiana Choirida Ahmad Zaqi Muttaqin Fika Ekayanti Hoirun Nisa Hari Hendarto Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis Journal of Personalized Medicine telemedicine metabolic dysfunction-associated fatty liver disease monitor lifestyle modification COVID-19 pandemic |
| title | Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
| title_full | Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
| title_fullStr | Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
| title_full_unstemmed | Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
| title_short | Telemedicine as an Option for Monitoring Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Patients Facing the COVID-19 Pandemic: A Systematic Review and Meta-Analysis |
| title_sort | telemedicine as an option for monitoring metabolic dysfunction associated fatty liver disease mafld patients facing the covid 19 pandemic a systematic review and meta analysis |
| topic | telemedicine metabolic dysfunction-associated fatty liver disease monitor lifestyle modification COVID-19 pandemic |
| url | https://www.mdpi.com/2075-4426/14/3/281 |
| work_keys_str_mv | AT femmynurulakbar telemedicineasanoptionformonitoringmetabolicdysfunctionassociatedfattyliverdiseasemafldpatientsfacingthecovid19pandemicasystematicreviewandmetaanalysis AT safirarosianachoirida telemedicineasanoptionformonitoringmetabolicdysfunctionassociatedfattyliverdiseasemafldpatientsfacingthecovid19pandemicasystematicreviewandmetaanalysis AT ahmadzaqimuttaqin telemedicineasanoptionformonitoringmetabolicdysfunctionassociatedfattyliverdiseasemafldpatientsfacingthecovid19pandemicasystematicreviewandmetaanalysis AT fikaekayanti telemedicineasanoptionformonitoringmetabolicdysfunctionassociatedfattyliverdiseasemafldpatientsfacingthecovid19pandemicasystematicreviewandmetaanalysis AT hoirunnisa telemedicineasanoptionformonitoringmetabolicdysfunctionassociatedfattyliverdiseasemafldpatientsfacingthecovid19pandemicasystematicreviewandmetaanalysis AT harihendarto telemedicineasanoptionformonitoringmetabolicdysfunctionassociatedfattyliverdiseasemafldpatientsfacingthecovid19pandemicasystematicreviewandmetaanalysis |